
STXS Valuation
Stereotaxis Inc
- Overview
- Forecast
- Valuation
STXS Relative Valuation
STXS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, STXS is overvalued; if below, it's undervalued.
Historical Valuation
Stereotaxis Inc (STXS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.23 is considered Undervalued compared with the five-year average of 7.39. The fair price of Stereotaxis Inc (STXS) is between 9.30 to 11.53 according to relative valuation methord. Compared to the current price of 1.99 USD , Stereotaxis Inc is Undervalued By 78.60%.
Relative Value
Fair Zone
9.30-11.53
Current Price:1.99
78.60%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
28.35
P/B
Median3y
10.45
Median5y
11.08
-4.91
FCF Yield
Median3y
-6.39
Median5y
-4.30
Competitors Valuation Multiple
The average P/S ratio for STXS's competitors is 93.26, providing a benchmark for relative valuation. Stereotaxis Inc Corp (STXS) exhibits a P/S ratio of 5.23, which is -94.39% above the industry average. Given its robust revenue growth of 38.88%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch

WOW
WideOpenWest Inc
4.350
USD
-3.12%

PRME
Prime Medicine Inc
1.570
USD
-6.55%

OABI
OmniAb Inc
1.680
USD
-4.00%

SENEA
Seneca Foods Corp
89.580
USD
-0.31%

MLP
Maui Land & Pineapple Company Inc
14.950
USD
-2.22%

JFIN
Jiayin Group Inc
12.430
USD
+10.49%

BRY
Berry Corporation (Bry)
2.390
USD
-7.72%

OLMA
Olema Pharmaceuticals Inc
5.560
USD
-1.07%

HBCP
Home Bancorp Inc
49.780
USD
-2.10%

RVNC
Revance Therapeutics Inc
3.650
USD
0.00%
FAQ

Is Stereotaxis Inc (STXS) currently overvalued or undervalued?
Stereotaxis Inc (STXS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 5.23 is considered Undervalued compared with the five-year average of 7.39. The fair price of Stereotaxis Inc (STXS) is between 9.30 to 11.53 according to relative valuation methord. Compared to the current price of 1.99 USD , Stereotaxis Inc is Undervalued By 78.60% .

What is Stereotaxis Inc (STXS) fair value?

How does STXS's valuation metrics compare to the industry average?

What is the current P/B ratio for Stereotaxis Inc (STXS) as of May 05 2025?

What is the current FCF Yield for Stereotaxis Inc (STXS) as of May 05 2025?

What is the current Forward P/E ratio for Stereotaxis Inc (STXS) as of May 05 2025?
